Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-27 @ 9:35 PM
Study NCT ID:
NCT00634361
Status:
COMPLETED
Last Update Posted:
2014-05-22
First Post:
2008-03-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ethyl-EPA Treatment of Prodromal Patients
Sponsor:
Yale University
Organization:
Study Overview
Official Title:
Ethyl-EPA Treatment of Prodromal Patients
Status:
COMPLETED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open-label trial of an omega-3 fatty acid for symptoms of the schizophrenia prodrome.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: